Companies · Manufacturing

Amyris, Inc.

EMERYVILLE · Manufacturing · https://amyris.com/

Diligence memoA one-page analyst read on Amyris, Inc. — recommendation, valuation, rhythm, risks.
$1.6B
Total raised · real
46
Rounds
0.0×
Latest step-up
Top 1%
Sector rank · raised
Recurring offerings
Latest stage · inferred · Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Amyris, Inc. has raised $1.6B over 46 rounds; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the manufacturing sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

At-risk
  • Last raise 3.8 yr ago; this sector typically re-raises about every 12 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Recurring offering issuermedium confidence

Amyris, Inc. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Program-like
Frequent filings and follow-ons read more like a securities offering program than discrete startup rounds.
Lifecycle
18.4 yr record
Peak capital year was 2020 with $303.4M across 3 filings.
Market position
ahead of 100% of Manufacturing peers
Capital scale is ahead of 100% of Manufacturing peers; modeled value is above 84% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Lower applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Some evidence
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • 54 dated financing filings, averaging about 3 months apart.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • Capital program peaked in 2020: $303.4M across 3 filings.
  • Largest single filing was $200.0M on 2020-06-05.
  • Filing rows sum to $1.9B, while canonical raised total is $1.6B; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Manufacturing

Amyris, Inc. is one of 3257 Manufacturing companies tracked from EMERYVILLE. By capital raised it ranks among the largest (ahead of 100% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst

Amyris is a vertically integrated biomanufacturing company that uses renewable biological chemistry to create, customize, and manufacture high-performance molecules and advance a more prosperous and resilient world.

Amyris is a vertically integrated biomanufacturing company that uses renewable biological chemistry to create, customize, and manufacture high-performance molecules and advance a more prosperous and resilient world. At Amyris, we have pioneered the use of microbes to transform abundant plant-derived sugars into high-performing molecules at scale. Our platform unlocks access to the exquisite, sophisticated chemistry found throughout living systems – leading to new product possibilities, market opportunities, and sustainability solutions. With proven scale, we are redefining what renewable chemistry can do. Create product differentiation, competitive advantage, and lasting value with biotechnology – while reducing environmental impact and emissions. Learn about our latest updates, from our scientific breakthroughs to our collaborations with partners to transform industries.

biotechclimate/cleantech
Find Amyris online

Trades publicly as Amyris.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2022-09-13
First sale
Amount raised vs valuation, by year

This issuer has a dense recurring filing history, so the chart groups filings by year. Solid bars are annual reported capital reported; hatched bars show the latest modeled value est. observed in that year. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Annual capital raised · realLatest value in year · estCumulative funded · real

Dense history compressed: 54 filings shown as 14 yearly buckets. Hover a bucket for filing count, annual capital, and latest modeled value.

$0$1.3B$2.5B$3.8B$5.0B2008: 1 filing Raised $2.4M total (real) Latest modeled valuation $29M (est)20081 filings2009: 2 filings Raised $86M total (real) Latest modeled valuation $271M (est)20092 filings2010: 3 filings Raised $195M total (real) Latest modeled valuation $157M (est)20103 filings2011: 1 filing Raised $7.0M total (real) Latest modeled valuation $80M (est)20111 filings2012: 6 filings Raised $222M total (real) Latest modeled valuation $481M (est)20126 filings2013: 5 filings Raised $183M total (real) Latest modeled valuation $978M (est)20135 filings2014: 3 filings Raised $37M total (real) Latest modeled valuation $247M (est)20143 filings2015: 3 filings Raised $224M total (real) Latest modeled valuation $656M (est)20153 filings2016: 8 filings Raised $78M total (real) Latest modeled valuation $285M (est)20168 filings2017: 5 filings Raised $140M total (real) Latest modeled valuation $285M (est)20175 filings2018: 4 filings Raised $196M total (real) Latest modeled valuation $683M (est)20184 filings2019: 9 filings Raised $177M total (real) Latest modeled valuation $44M (est)20199 filings2020: 3 filings Raised $303M total (real) Latest modeled valuation $2.3B (est)20203 filings2022: 1 filing Raised $8.0M total (real) Latest modeled valuation $77M (est)20221 filingsCumulative $1.9B

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps

This looks like a recurring offering series, so a VC stage ladder would be misleading. Showing the filed offering sequence instead.

Initial offering$2.4M · 2008
Follow-on offering$61.1M · 2009
Follow-on offering$24.7M · 2009
Follow-on offering$47.8M · 2010
Follow-on offering$133.2M · 2010
Follow-on offering$13.8M · 2010
Follow-on offering$7.0M · 2011
Follow-on offering$58.7M · 2012
Follow-on offering$25.0M · 2012
Follow-on offering$4.1M · 2012
Follow-on offering$53.3M · 2012
Follow-on offering$38.3M · 2012
Follow-on offering$42.2M · 2012
Follow-on offering$5.0M · 2013
Follow-on offering$30.0M · 2013
Follow-on offering$10.0M · 2013
Follow-on offering$51.8M · 2013
Follow-on offering$85.9M · 2013
Follow-on offering$4.0M · 2014
Follow-on offering$10.8M · 2014
Follow-on offering$21.7M · 2014
Follow-on offering$25.0M · 2015
Follow-on offering$141.0M · 2015
Follow-on offering$57.6M · 2015

Showing first 24 of 54 filings to keep the sequence readable.

Modeled valuation trajectory
$77.1M
Base estimate est.
$46.2M
Conservative case
$131.5M
Upside case
$66.7M
Modeled post-money

This issuer files recurring offerings, so the model treats stage labels as a loose sizing heuristic, not a clean VC ladder. The estimate anchors on reported filing amounts and dates, then applies benchmark dilution, survival, and markup assumptions. Directional, not a quoted figure.

Seed · modeled $28.9M · 2008-02-072008Series C · modeled $691.2M · 2009-07-31Series B · modeled $271.4M · 2009-07-31Series C · modeled $541.4M · 2010-03-19Series D+ · modeled $1.5B · 2010-06-21Series D+ · modeled $156.9M · 2010-09-30Series D+ · modeled $79.7M · 2011-10-13Series D+ · modeled $668.8M · 2012-02-23Series D+ · modeled $284.7M · 2012-02-27Series D+ · modeled $46.7M · 2012-05-18Series D+ · modeled $607.0M · 2012-07-31Series B · modeled $419.9M · 2012-07-31Series D+ · modeled $481.2M · 2012-12-24Series D+ · modeled $56.9M · 2013-03-27Series D+ · modeled $341.7M · 2013-06-06Series A · modeled $99.9M · 2013-06-06Series C · modeled $586.4M · 2013-10-16Series D+ · modeled $977.9M · 2013-10-16Series D+ · modeled $45.6M · 2014-04-14Series A · modeled $108.4M · 2014-07-31Series D+ · modeled $247.1M · 2014-07-31Series D+ · modeled $284.7M · 2015-07-29Series D+ · modeled $1.6B · 2015-07-29Series D+ · modeled $656.1M · 2015-10-20Series D+ · modeled $227.8M · 2016-02-12Series D+ · modeled $56.9M · 2016-05-10Series D+ · modeled $56.9M · 2016-06-24Series D+ · modeled $33.0M · 2016-08-06Series D+ · modeled $68.3M · 2016-10-21Series D+ · modeled $96.8M · 2016-10-27Series D+ · modeled $65.2M · 2016-11-16Series D+ · modeled $284.7M · 2016-12-31Series D+ · modeled $217.9M · 2017-01-11Series D+ · modeled $742.6M · 2017-05-08Series D+ · modeled $64.9M · 2017-05-31Series D+ · modeled $284.7M · 2017-08-02Series D+ · modeled $284.7M · 2017-08-02Series D+ · modeled $434.1M · 2018-04-12Series D+ · modeled $1.0B · 2018-08-17Series D+ · modeled $82.6M · 2018-11-19Series D+ · modeled $683.3M · 2018-12-06Series D+ · modeled $405.1M · 2019-04-15Series D+ · modeled $850.6M · 2019-04-24Series D+ · modeled $112.4M · 2019-08-14Series D+ · modeled $216.4M · 2019-08-28Series D+ · modeled $142.4M · 2019-09-10Series D+ · modeled $65.4M · 2019-10-11Series D+ · modeled $88.2M · 2019-10-28Series D+ · modeled $89.4M · 2019-11-14Series D+ · modeled $44.1M · 2019-11-27Series D+ · modeled $111.0M · 2020-01-14Series D+ · modeled $1.1B · 2020-01-31Series D+ · modeled $2.3B · 2020-06-05Series D+ · modeled $77.1M · 2022-09-132022
Model inputs · modeled:benchmark-stage-stepup-v1
12%
Dilution assumption
Implied ownership sold in the financing.
87%
Survival probability
69% low · 96% high
1.08×/yr
Annual markup
1.21×/yr upside case
3.8 yr
Elapsed time used
3.8 yr actual, capped for stale marks
manufacturing
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
3 mo
Avg between rounds
$111.9M/yr
Capital velocity
18.4 yr
On record since
2008
First round
54
Rounds on file
How it compares to the market

Benchmarked against 3257 companies in Manufacturing. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 807× above median
This company$1.6B
Sector median$2.0M
Modeled value — vs sector median (estimate, all stages) 6.4× above median
This company$77.1M
Sector median$12.0M

Raised more than 100% of sector peers (real $). Modeled value above 84% of peers (estimate).

Full financing history

This issuer files too frequently for VC stage labels to be meaningful, so rows are shown as initial/follow-on offerings est. instead of Pre-Seed/Seed/Series buckets.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Initial offering$2.4M2008-02-07$11.8M$28.9M85%
Follow-on offering$61.1M2009-07-31$407.2M$691.2M85%
Follow-on offering$24.7M2009-07-31$137.5M$271.4M85%
Follow-on offering$47.8M2010-03-19$319.0M$541.4M85%
Follow-on offering$133.2M2010-06-21$1.1B$1.5B85%
Follow-on offering$13.8M2010-09-30$114.8M$156.9M85%
Follow-on offering$7.0M2011-10-13$58.3M$79.7M85%
Follow-on offering$58.7M2012-02-23$489.4M$668.8M85%
Follow-on offering$25.0M2012-02-27$208.3M$284.7M85%
Follow-on offering$4.1M2012-05-18$34.1M$46.7M85%
Follow-on offering$53.3M2012-07-31$444.2M$607.0M85%
Follow-on offering$38.3M2012-07-31$212.8M$419.9M85%
Follow-on offering$42.2M2012-12-24$352.1M$481.2M85%
Follow-on offering$5.0M2013-03-27$41.7M$56.9M85%
Follow-on offering$30.0M2013-06-06$250.0M$341.7M85%
Follow-on offering$10.0M2013-06-06$45.5M$99.9M85%
Follow-on offering$51.8M2013-10-16$345.5M$586.4M85%
Follow-on offering$85.9M2013-10-16$715.5M$977.9M85%
Follow-on offering$4.0M2014-04-14$33.3M$45.6M85%
Follow-on offering$10.8M2014-07-31$49.3M$108.4M85%
Follow-on offering$21.7M2014-07-31$180.8M$247.1M85%
Follow-on offering$25.0M2015-07-29$208.3M$284.7M85%
Follow-on offering$141.0M2015-07-29$1.2B$1.6B85%
Follow-on offering$57.6M2015-10-20$480.0M$656.1M85%
Follow-on offering$20.0M2016-02-12$166.7M$227.8M85%
Follow-on offering$5.0M2016-05-10$41.7M$56.9M85%
Follow-on offering$5.0M2016-06-24$41.7M$56.9M85%
Follow-on offering$2.9M2016-08-06$24.2M$33.0M85%
Follow-on offering$6.0M2016-10-21$50.0M$68.3M90%
Follow-on offering$8.5M2016-10-27$70.8M$96.8M90%
Follow-on offering$5.7M2016-11-16$47.7M$65.2M90%
Follow-on offering$25.0M2016-12-31$208.3M$284.7M90%
Follow-on offering$19.1M2017-01-11$159.5M$217.9M90%
Follow-on offering$65.2M2017-05-08$543.4M$742.6M90%
Follow-on offering$5.7M2017-05-31$47.5M$64.9M90%
Follow-on offering$25.0M2017-08-02$208.3M$284.7M90%
Follow-on offering$25.0M2017-08-02$208.3M$284.7M90%
Follow-on offering$38.1M2018-04-12$317.6M$434.1M90%
Follow-on offering$91.0M2018-08-17$758.1M$1.0B90%
Follow-on offering$7.3M2018-11-19$60.4M$82.6M90%
Follow-on offering$60.0M2018-12-06$500.0M$683.3M90%
Follow-on offering$35.6M2019-04-15$296.4M$405.1M90%
Follow-on offering$74.7M2019-04-24$622.4M$850.6M90%
Follow-on offering$9.9M2019-08-14$82.2M$112.4M90%
Follow-on offering$19.0M2019-08-28$158.3M$216.4M90%
Follow-on offering$12.5M2019-09-10$104.2M$142.4M90%
Follow-on offering$5.7M2019-10-11$47.8M$65.4M90%
Follow-on offering$7.7M2019-10-28$64.5M$88.2M90%
Follow-on offering$7.8M2019-11-14$65.4M$89.4M90%
Follow-on offering$3.9M2019-11-27$32.3M$44.1M90%
Follow-on offering$9.8M2020-01-14$81.3M$111.0M90%
Follow-on offering$93.7M2020-01-31$780.6M$1.1B90%
Follow-on offering$200.0M2020-06-05$1.7B$2.3B90%
Follow-on offering$8.0M2022-09-13$66.7M$77.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Initial offering$2.4M2008-02-07
    • First recorded raise — entered as Initial offering.
    • 3 investors on this round.
  2. Follow-on offering$61.1M2009-07-31
    • Raised 18 mo later, in step with the ~12 mo sector norm.
    • Round 25.9× larger than the prior — scaling up.
    • 34 investors on this round.
  3. Follow-on offering$24.7M2009-07-31
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.5× smaller than the prior — bridge or down round.
    • 8 investors on this round.
  4. Follow-on offering$47.8M2010-03-19
    • Raised 8 mo later, in step with the ~12 mo sector norm.
    • Round 1.9× larger than the prior — scaling up.
    • 1 investor on this round.
  5. Follow-on offering$133.2M2010-06-21
    • Came back fast: 3 mo vs the ~12 mo sector norm.
    • Round 2.8× larger than the prior — scaling up.
    • 1 investor on this round.
  6. Follow-on offering$13.8M2010-09-30
    • Came back fast: 3 mo vs the ~12 mo sector norm.
    • Round 9.7× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  7. Follow-on offering$7.0M2011-10-13
    • Raised 12 mo later, in step with the ~12 mo sector norm.
    • Round 2.0× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  8. Follow-on offering$58.7M2012-02-23
    • Came back fast: 4 mo vs the ~12 mo sector norm.
    • Round 8.4× larger than the prior — scaling up.
    • 6 investors on this round.
  9. Follow-on offering$25.0M2012-02-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.3× smaller than the prior — bridge or down round.
    • 14 investors on this round.
  10. Follow-on offering$4.1M2012-05-18
    • Came back fast: 3 mo vs the ~12 mo sector norm.
    • Round 6.1× smaller than the prior — bridge or down round.
    • 5 investors on this round.
  11. Follow-on offering$53.3M2012-07-31
    • Came back fast: 2 mo vs the ~12 mo sector norm.
    • Round 13.0× larger than the prior — scaling up.
    • 1 investor on this round.
  12. Follow-on offering$38.3M2012-07-31
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  13. Follow-on offering$42.2M2012-12-24
    • Came back fast: 5 mo vs the ~12 mo sector norm.
    • Round roughly the size of the prior one.
    • 7 investors on this round.
  14. Follow-on offering$5.0M2013-03-27
    • Came back fast: 3 mo vs the ~12 mo sector norm.
    • Round 8.4× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  15. Follow-on offering$30.0M2013-06-06
    • Came back fast: 2 mo vs the ~12 mo sector norm.
    • Round 6.0× larger than the prior — scaling up.
    • 1 investor on this round.
  16. Follow-on offering$10.0M2013-06-06
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.0× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  17. Follow-on offering$51.8M2013-10-16
    • Came back fast: 4 mo vs the ~12 mo sector norm.
    • Round 5.2× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 3 investors on this round.
  18. Follow-on offering$85.9M2013-10-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.7× larger than the prior — scaling up.
    • 3 investors on this round.
  19. Follow-on offering$4.0M2014-04-14
    • Came back fast: 6 mo vs the ~12 mo sector norm.
    • Round 21.5× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  20. Follow-on offering$10.8M2014-07-31
    • Came back fast: 4 mo vs the ~12 mo sector norm.
    • Round 2.7× larger than the prior — scaling up.
    • 1 investor on this round.
  21. Follow-on offering$21.7M2014-07-31
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.0× larger than the prior — scaling up.
    • 1 investor on this round.
  22. Follow-on offering$25.0M2015-07-29
    • Raised 12 mo later, in step with the ~12 mo sector norm.
    • Round roughly the size of the prior one.
    • 7 investors on this round.
  23. Follow-on offering$141.0M2015-07-29
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 5.6× larger than the prior — scaling up.
    • 2 investors on this round.
  24. Follow-on offering$57.6M2015-10-20
    • Came back fast: 3 mo vs the ~12 mo sector norm.
    • Round 2.4× smaller than the prior — bridge or down round.
    • 31 investors on this round.
  25. Follow-on offering$20.0M2016-02-12
    • Came back fast: 4 mo vs the ~12 mo sector norm.
    • Round 2.9× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  26. Follow-on offering$5.0M2016-05-10
    • Came back fast: 3 mo vs the ~12 mo sector norm.
    • Round 4.0× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  27. Follow-on offering$5.0M2016-06-24
    • Came back fast: 1 mo vs the ~12 mo sector norm.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  28. Follow-on offering$2.9M2016-08-06
    • Came back fast: 1 mo vs the ~12 mo sector norm.
    • Round 1.7× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  29. Follow-on offering$6.0M2016-10-21
    • Came back fast: 2 mo vs the ~12 mo sector norm.
    • Round 2.1× larger than the prior — scaling up.
    • 1 investor on this round.
  30. Follow-on offering$8.5M2016-10-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× larger than the prior — scaling up.
    • 1 investor on this round.
  31. Follow-on offering$5.7M2016-11-16
    • Came back fast: 1 mo vs the ~12 mo sector norm.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  32. Follow-on offering$25.0M2016-12-31
    • Came back fast: 1 mo vs the ~12 mo sector norm.
    • Round 4.4× larger than the prior — scaling up.
    • 1 investor on this round.
  33. Follow-on offering$19.1M2017-01-11
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 7 investors on this round.
  34. Follow-on offering$65.2M2017-05-08
    • Came back fast: 4 mo vs the ~12 mo sector norm.
    • Round 3.4× larger than the prior — scaling up.
    • 22 investors on this round.
  35. Follow-on offering$5.7M2017-05-31
    • Came back fast: 1 mo vs the ~12 mo sector norm.
    • Round 11.4× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  36. Follow-on offering$25.0M2017-08-02
    • Came back fast: 2 mo vs the ~12 mo sector norm.
    • Round 4.4× larger than the prior — scaling up.
    • 1 investor on this round.
  37. Follow-on offering$25.0M2017-08-02
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 2 investors on this round.
  38. Follow-on offering$38.1M2018-04-12
    • Raised 8 mo later, in step with the ~12 mo sector norm.
    • Round 1.5× larger than the prior — scaling up.
    • 11 investors on this round.
  39. Follow-on offering$91.0M2018-08-17
    • Came back fast: 4 mo vs the ~12 mo sector norm.
    • Round 2.4× larger than the prior — scaling up.
    • 3 investors on this round.
  40. Follow-on offering$7.3M2018-11-19
    • Came back fast: 3 mo vs the ~12 mo sector norm.
    • Round 12.5× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  41. Follow-on offering$60.0M2018-12-06
    • Came back fast: 1 mo vs the ~12 mo sector norm.
    • Round 8.3× larger than the prior — scaling up.
    • 2 investors on this round.
  42. Follow-on offering$35.6M2019-04-15
    • Came back fast: 4 mo vs the ~12 mo sector norm.
    • Round 1.7× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  43. Follow-on offering$74.7M2019-04-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.1× larger than the prior — scaling up.
    • 9 investors on this round.
  44. Follow-on offering$9.9M2019-08-14
    • Came back fast: 4 mo vs the ~12 mo sector norm.
    • Round 7.6× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  45. Follow-on offering$19.0M2019-08-28
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.9× larger than the prior — scaling up.
    • 1 investor on this round.
  46. Follow-on offering$12.5M2019-09-10
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  47. Follow-on offering$5.7M2019-10-11
    • Came back fast: 1 mo vs the ~12 mo sector norm.
    • Round 2.2× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  48. Follow-on offering$7.7M2019-10-28
    • Came back fast: 1 mo vs the ~12 mo sector norm.
    • Round 1.3× larger than the prior — scaling up.
    • 1 investor on this round.
  49. Follow-on offering$7.8M2019-11-14
    • Came back fast: 1 mo vs the ~12 mo sector norm.
    • Round roughly the size of the prior one.
    • 2 investors on this round.
  50. Follow-on offering$3.9M2019-11-27
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.0× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  51. Follow-on offering$9.8M2020-01-14
    • Came back fast: 2 mo vs the ~12 mo sector norm.
    • Round 2.5× larger than the prior — scaling up.
    • 4 investors on this round.
  52. Follow-on offering$93.7M2020-01-31
    • Came back fast: 1 mo vs the ~12 mo sector norm.
    • Round 9.6× larger than the prior — scaling up.
    • 7 investors on this round.
  53. Follow-on offering$200.0M2020-06-05
    • Came back fast: 4 mo vs the ~12 mo sector norm.
    • Round 2.1× larger than the prior — scaling up.
    • 53 investors on this round.
  54. Follow-on offering$8.0M2022-09-13
    • Raised again after 27 mo — slower than the ~12 mo sector norm.
    • Round 25.0× smaller than the prior — bridge or down round.
    • 1 investor on this round.
Intelligence
2022 ~Q4
Modeled next raise · ~3mo cadence
$8.0M
Modeled next size est.range $8.0M$12.8M
0.0×
Last step-up
$111.9M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Samir Kaul31 other2008-02
JOHN DOERR13 other2008-02
Geoff Duyk4 other2008-02
L. John Doerr3 other2015-07
Neil Renninger3 other2008-02
John Melo2 other2008-02
Patrick Pichette2 other2010-06
Philippe Boisseau2 other2011-10
Carole Piwnica1 other2009-07
EDUARDO ALVAREZ1 other2018-04
Fernando De Castro Reinach1 other2011-10
Fernando Reinach1 other2008-02
GEOFFREY DUYK1 other2013-10
Jeryl Hilleman1 other2008-02
Margaret Georgiadis1 other2016-02
Peter Boynton1 other2010-06
RAFFI ASADORIAN1 other2014-07
Ralph Alexander1 other2008-02
R NEIL WILLIAMS1 other2015-07
Tamara Tompkins1 other2008-02
ABRAHAM JOHN KLAEIJSEN2015-07
Abraham Klaeijsen2016-02
ANA JOHN DUTRA2022-09
Arthur Levinson2010-06
Registry & provenance

Amyris, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1365916
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Elevance Renewable Sciences, Inc.ManufacturingSeries D+$319.9M$208.4Mnetwork2 shared operators · same sector · same stage
Renmatix, Inc.ManufacturingSeries C$141.3M$550.4Mnetwork2 shared operators · same sector
S & P Ingredient Development, LLCManufacturingSeries B$93.6M$43.3Mnetwork1 shared operator · same sector
V Vehicle CoManufacturingSeries C$65.7M$704.4Mnetwork1 shared operator · same sector
AppLovin CorpGamingSeries D+$585.8M$2.7Bnetwork1 shared operator · same stage
Victory Innovations Holdings, LLCManufacturingSeries D+$160.0M$99.3Msame sector · same stage
Guardant Health, Inc.BiotechnologySeries D+$500.0M$13.2Bnetwork1 shared operator · same stage
Lightspeed POS Inc.Other TechnologyGrowth/Late$1.5B$10.7Bnetwork1 shared operator
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Amydis, Inc.BiotechnologySeries A$20.5M75%
Naveris, Inc.BiotechnologySeries B$126.9M75%
Sophiris Bio Inc.BiotechnologySeries A$183.2M74%
Lygos, Inc.
Lygos engineers yeast to convert sugar into high-value industrial…
BiotechSeries B$432.7M73%
Artiva Biotherapeutics, Inc.BiotechnologySeries D+$4.0B73%
MatriSys Bioscience, Inc.BiotechnologySeries A$113.7M73%
Cascade Biocatalysts, Inc.BiotechnologySeries A$16.8M73%
TeVido BioDevices, Inc.BiotechnologySeed$63.1M72%
Frequently asked
How much funding has Amyris, Inc. raised?
Amyris, Inc. has raised approximately $1.6B in disclosed capital across 46 recorded financing rounds, aggregated from public filings.
What is Amyris, Inc.'s estimated valuation?
Provath's modeled valuation for Amyris, Inc. is approximately $77.1M (modeled range $46.2M–$131.5M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Amyris, Inc. at?
Amyris, Inc. shows a recurring offering pattern rather than a clean VC stage progression. Its most recent recorded round closed around Tue Sep 13.
What does Amyris, Inc. do and where is it based?
Amyris, Inc. operates in the Manufacturing sector, based in EMERYVILLE. Amyris is a vertically integrated biomanufacturing company that uses renewable biological chemistry to create, customize, and manufacture high-performance molecules and advance a more prosperous and resilient world.
Explore related

See where Amyris, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Amyris, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.